Gene · 23600
Papers2,301
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,301
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrative multi-omics analysis identifies mitochondria- and ferroptosis-related prognostic genes in cervical cancer. | Exp Cell Res | 2025 | 41106766 | PubTator, text mining | PubMed |
| The diagnostic value of urinary exosomes in prostate cancer: a prospective multicenter study. | BMC Urol | 2025 | 41034937 | PubTator, text mining | PubMed |
| Oesophageal metastasis of prostate cancer: a case report. | Discov Oncol | 2025 | 41003910 | PubTator, text mining | PubMed |
| Papillary renal neoplasm with reverse polarity: a case report and literature review. | Front Oncol | 2025 | 40989704 | PubTator, text mining | PubMed |
| Malignant Brenner tumor with extensive clear cell features: A valuable diagnostic lesson learned from molecular tumor profiling and AI-based tumor differential tool. | Gynecol Oncol Rep | 2025 | 40977830 | PubTator, text mining | PubMed |
| Clonal divergence and genomic meltdown in prostatic pleomorphic giant cell adenocarcinoma. | Front Immunol | 2025 | 40873563 | PubTator, text mining | PubMed |
| PTEN and ERG Biomarkers as Predictors of Biochemical Recurrence Risk in Patients Undergoing Radical Prostatectomy. | Diseases | 2025 | 40863209 | PubTator, text mining | PubMed |
| Bilateral, multicystic fumarate hydratase-deficient renal cell carcinoma in patient with hereditary leiomyomatosis & renal cell carcinoma syndrome: A case report and review of the literature. | Diagn Pathol | 2025 | 40859301 | PubTator, text mining | PubMed |
| Comparative transcriptomic analysis reveals bioluminescence-related genes in firely Pyrocoelia pectoralis. | Genomics | 2025 | 40858179 | PubTator, text mining | PubMed |
| Treatment of Inborn Errors by Product Replacement: The Example of Inborn Errors of Bile Acid Synthesis. | J Inherit Metab Dis | 2025 | 40847535 | PubTator, text mining | PubMed |
| Cholic acid as a treatment for cerebrotendinous xanthomatosis: a comprehensive review of safety and efficacy. | Orphanet J Rare Dis | 2025 | 40731019 | PubTator, text mining | PubMed |
| Immunosensor Enhanced with Silver Nanocrystals for On-Chip Prostate-Specific Antigen Detection. | Biosensors (Basel) | 2025 | 40710078 | PubTator, text mining | PubMed |
| Ductal Adenocarcinoma of the Prostate Presenting With Bladder Invasion and Bone Metastasis: A Case Report. | Cureus | 2025 | 40662003 | PubTator, text mining | PubMed |
| Effectiveness and Safety of Personalized Cholic Acid Treatment in Patients With Bile Acid Synthesis Defects. | J Inherit Metab Dis | 2025 | 40643170 | PubTator, text mining | PubMed |
| Clear Cell Papillary Renal Cell Carcinoma Incidentally Discovered in a Patient With Normal Renal Function: A Case Report. | IJU Case Rep | 2025 | 40607469 | PubTator, text mining | PubMed |
| AMACR is a highly sensitive and specific immunohistochemical marker for diagnosing prostate cancer on biopsy: a systematic review and meta-analysis. | J Pathol Transl Med | 2025 | 40605376 | PubTator, text mining | PubMed |
| Comprehensive Analysis of 15 Cases of ELOC -RCC and Identification of Novel Mutation Site. | Am J Surg Pathol | 2025 | 40557827 | PubTator, text mining | PubMed |
| A Novel Primary Cell Line Model of Localized Prostate Cancer and Radioresistance-A Role for Nicotinamide N-Methyltransferase. | Cells | 2025 | 40497995 | PubTator, text mining | PubMed |
| Association of Gleason Patterns with α-Methylacyl-Coa Racemase (AMACR) Immunohistochemistry Reaction. | Clin Lab | 2025 | 40497626 | PubTator, text mining | PubMed |
| TFE3-rearranged renal cell carcinoma - Expanding the histomorphological spectrum. | Indian J Pathol Microbiol | 2025 | 40485553 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23600/papers?page=4